Nehal E. Elsadek
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 7
- Extracellular vesicles in disease 3
-
- Immunotherapy and Immune Responses 5
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Taro Shimizu (13 shared papers)Sherif E. Emam (14 shared papers)Tatsuhiro Ishida (14 shared papers)Hidenori Ando (13 shared papers)Yu Ishima (12 shared papers)Hatem A. Sarhan (5 shared papers)Amal K. Hussein (2 shared papers)Mohamed Yousif Ibrahim (1 shared paper)
- Journals
- Journal of Controlled Release (4 papers)Molecular Pharmaceutics (2 papers)International Journal of Pharmaceutics (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Biological and Pharmaceutical Bulletin (2 papers)
- Partner nations
- EgyptJapanSaudi Arabia
In The Last Decade
Nehal E. Elsadek
16 papers receiving 603 citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Biomaterials 201
- Pharmaceutical Science 58
- Cancer Research 70
- Immunology 93
- Molecular Biology 297
Countries citing papers authored by Nehal E. Elsadek
This map shows the geographic impact of Nehal E. Elsadek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehal E. Elsadek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehal E. Elsadek more than expected).
Fields of papers citing papers by Nehal E. Elsadek
This network shows the impact of papers produced by Nehal E. Elsadek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehal E. Elsadek. The network helps show where Nehal E. Elsadek may publish in the future.
Co-authors
The 22 scholars most cited alongside Nehal E. Elsadek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products Hit paper breakdown → | 2022 | 286 |
| 2 | 2019 | 65 | |
| 3 | 2021 | 58 | |
| 4 | 2020 | 44 | |
| 5 | 2022 | 33 | |
| 6 | 2020 | 31 | |
| 7 | 2023 | 22 | |
| 8 | 2020 | 20 | |
| 9 | 2022 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 2 | |
| 16 | 2022 | 1 | |
| 17 | 2025 | 0 |
About Nehal E. Elsadek
Nehal E. Elsadek is a scholar working on Molecular Biology, Immunology, Biomaterials, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 614 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (5 papers), Extracellular vesicles in disease (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), COVID-19 Impact on Reproduction (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Biomaterials (201 citations), Pharmaceutical Science (58 citations), Cancer Research (70 citations), Immunology (93 citations) and Molecular Biology (297 citations). Nehal E. Elsadek has collaborated with scholars based in Egypt, Japan and Saudi Arabia. Frequent co-authors include Taro Shimizu, Sherif E. Emam, Tatsuhiro Ishida, Hidenori Ando, Yu Ishima, Hatem A. Sarhan, Amal K. Hussein, Mohamed Yousif Ibrahim, Omar H. El-Garhy and Eslam Ramadan. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.